Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Todd

Showing results (351-360 of 385) with videos related to

Pageof 39
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2023
Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter studyJamie L Todd, Jeremy M Weber, Francine L Kelly, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 11, 2020
International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantationTereza Martinu, Angela Koutsokera, Christian Benden, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2017
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary FibrosisSlavé Petrovski, Jamie L Todd, Michael T Durheim, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Clinical Features Associated with Chronic Lung Allograft Dysfunction Progression in a Multicenter CohortJamie L Todd, Megan L Neely, Jesse Y Hsu, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
American Journal of Respiratory and Critical Care Medicine|April 13, 2022
Rare and Common Variants in <i>KIF15</i> Contribute to Genetic Risk of Idiopathic Pulmonary FibrosisDavid Zhang, Gundula Povysil, Philippe H Kobeissy, et al.
Scientific Reports|November 27, 2019
Expression of the BAD pathway is a marker of triple-negative status and poor outcomeBernadette M Boac, Forough Abbasi, Roohi Ismail-Khan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 24, 2024
Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunctionJamie L Todd, Jeremy M Weber, Francine L Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Pageof 39

Showing results (351-360 of 385) with videos related to

Sort By:
Pageof 39
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2023
Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter studyJamie L Todd, Jeremy M Weber, Francine L Kelly, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 11, 2020
International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantationTereza Martinu, Angela Koutsokera, Christian Benden, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2017
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary FibrosisSlavé Petrovski, Jamie L Todd, Michael T Durheim, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Clinical Features Associated with Chronic Lung Allograft Dysfunction Progression in a Multicenter CohortJamie L Todd, Megan L Neely, Jesse Y Hsu, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
American Journal of Respiratory and Critical Care Medicine|April 13, 2022
Rare and Common Variants in <i>KIF15</i> Contribute to Genetic Risk of Idiopathic Pulmonary FibrosisDavid Zhang, Gundula Povysil, Philippe H Kobeissy, et al.
Scientific Reports|November 27, 2019
Expression of the BAD pathway is a marker of triple-negative status and poor outcomeBernadette M Boac, Forough Abbasi, Roohi Ismail-Khan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 24, 2024
Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunctionJamie L Todd, Jeremy M Weber, Francine L Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Pageof 39